In section Market Quotes
Vericel shares climbed 12% to $50.84 in midday trading after the company reported stronger third-quarter results and lifted its 2026 revenue forecast. The stock touched $55.60 earlier in the session, a 52-week high.
Revenue for the quarter reached $85.4 million, up from $67.5 million a year earlier and above the $77.9 million expected by analysts polled by FactSet. Net income rose to $14.2 million, or 27 cents a share, from $5.07 million, or 10 cents a share, in the year-earlier quarter. Analysts had expected a profit of $3.1 million, or 6 cents a share.
Revenue in Vericel’s Burn Care segment increased 52% to $18 million. Epicel revenue was $12.7 million.
The company now expects 2026 revenue of $344 million to $346 million, up from its previous forecast of $330 million to $340 million. Analysts are forecasting $336.3 million. Vericel also raised its Burn Care revenue guidance to $54 million, from an earlier range of $46 million to $50 million.
Comments (0)
No comments yet. Be the first!